438 related articles for article (PubMed ID: 29970827)
1. Recent Insights on Alzheimer's Disease Originating from Yeast Models.
Seynnaeve D; Vecchio MD; Fruhmann G; Verelst J; Cools M; Beckers J; Mulvihill DP; Winderickx J; Franssens V
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29970827
[TBL] [Abstract][Full Text] [Related]
2. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
Porzoor A; Macreadie IG
J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Disease: Significant Benefit from the Yeast-Based Models.
Epremyan KK; Mamaev DV; Zvyagilskaya RA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372938
[TBL] [Abstract][Full Text] [Related]
4. UBB
Chen X; Muñoz-Arellano AJ; Petranovic D
Aging (Albany NY); 2021 Nov; 13(21):23953-23980. PubMed ID: 34751669
[TBL] [Abstract][Full Text] [Related]
5. Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease.
Moosavi B; Mousavi B; Macreadie IG
J Alzheimers Dis; 2015; 47(1):9-16. PubMed ID: 26402750
[TBL] [Abstract][Full Text] [Related]
6. Application of yeast to studying amyloid and prion diseases.
Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
[TBL] [Abstract][Full Text] [Related]
7. The Ubiquitin System in Alzheimer's Disease.
Harris LD; Jasem S; Licchesi JDF
Adv Exp Med Biol; 2020; 1233():195-221. PubMed ID: 32274758
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-proteasome system in Alzheimer's disease.
Oddo S
J Cell Mol Med; 2008 Apr; 12(2):363-73. PubMed ID: 18266959
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.
Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H
Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348
[TBL] [Abstract][Full Text] [Related]
10. Amyloid protein-induced sequestration of the eukaryotic ribosome: effect of stoichiometry and polyphenolic inhibitors.
Ferdosh S; Banerjee S; Singh J; Barat C
FEBS Lett; 2022 May; 596(9):1190-1202. PubMed ID: 35114013
[TBL] [Abstract][Full Text] [Related]
11. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
12. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
13. Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease.
Weng FL; He L
Neurobiol Aging; 2021 Mar; 99():79-85. PubMed ID: 33422896
[TBL] [Abstract][Full Text] [Related]
14. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
[TBL] [Abstract][Full Text] [Related]
15. Yeast as a Model for Alzheimer's Disease: Latest Studies and Advanced Strategies.
Verduyckt M; Vignaud H; Bynens T; Van den Brande J; Franssens V; Cullin C; Winderickx J
Methods Mol Biol; 2016; 1303():197-215. PubMed ID: 26235068
[TBL] [Abstract][Full Text] [Related]
16. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.
Lin LF; Luo HM
Neurosci Bull; 2011 Feb; 27(1):53-60. PubMed ID: 21270904
[TBL] [Abstract][Full Text] [Related]
17. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
18. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
19. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
20. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
